THEBUSINESSBYTES
BUREAU
BENGALURU,
JULY 6, 2026
Bengaluru-based
Manipal Health Enterprises Ltd has received approval from the Securities and
Exchange Board of India (SEBI) for its proposed ₹8,000-crore initial public offering (IPO),
paving the way for one of the significant healthcare sector listings in recent
times.
The company secured
SEBI's approval on Monday after filing its draft IPO papers with the capital
markets regulator on March 25, 2026.
According to the
draft offer document, the IPO will comprise a fresh issue of equity shares
worth up to ₹8,000
crore and an offer for sale (OFS) of up to 43,227,668 equity shares by existing
shareholders.
The promoters
participating in the OFS include Imperius Healthcare Investments Pte. Ltd. and
Manipal Education and Medical Group India Private Limited. Several marquee
investors will also dilute their holdings through the offer, including TPG SG
Magazine Pte Ltd, Seventy Second Investment Company LLC, Ammar Sdn Bhd, Novo
Holdings Invest Asia A/S and Phoenix Bear Investments, LLC.
The fresh issue
proceeds are expected to strengthen the company's balance sheet and support its
growth strategy, while the OFS will provide an exit opportunity to existing
shareholders.
With SEBI's clearance
now in place, Manipal Health Enterprises is expected to move ahead with the
launch of its IPO, subject to prevailing market conditions and other regulatory
requirements.
